Bryce Point Capital, LLC

SEC CIK: 0002019492
Latest filing: Nov 6, 2025

SEC filings (opens in a new tab)

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by Bryce Point Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overview All 13F holders of CPRX Full Q3 2025 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2024

Holdings of CPRX by Bryce Point Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−20,608−100.0%	Sold out	Holders
Q1 2025	20,608	$506.7K	0.4%	−33,750−62.1%	Reduced	Holders
Q4 2024	54,358	$1.13M	0.3%	–	No prior filing	Holders